Yes, but management may also consider exclusive licensing deal with performance milestones to somewhat de-risk the binary event.
Maybe ATX are considering a licensing deal with a Major Korean pharma as we speak.
JMHO, DYOR.
Yes, but management may also consider exclusive licensing deal...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $116.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 23.5¢ | $927.2K | 3.837M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25807 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 899 | 1 |
View Market Depth
| Last trade - 15.58pm 31/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |